Nature3y
Precision protein engineering to target oncology
Sutro Biopharma, a drug development and manufacturing company headquartered in South San Francisco, is transforming biotherapeutics discovery with a novel platform for cell-free protein synthesis ...
PharmiWeb7d
Sutro Biopharma and Boehringer Ingelheim BioXcellenceâ„¢ collaboration: Established first-in-class cell-free capabilities at commercial scale
Boehringer Ingelheim BioXcellence™ and Sutro Biopharma Inc. today announced that they successfully applied Sutro’s proprietary cell-free expression technology on a commercial scale to manufacture ...
Benzinga.com1mon
2STRO : Expert Outlook: Sutro Biopharma Through The Eyes Of 6 Analysts
Throughout the last three months, 6 analysts have evaluated Sutro Biopharma STRO, offering a diverse set of opinions from bullish to bearish. The following table encapsulates their recent ratings ...
Yahoo Finance27d
Sutro Biopharma, Inc.'s (NASDAQ:STRO) latest 24% decline adds to one-year losses, institutional investors may consider drastic measures
A look at the shareholders of Sutro Biopharma, Inc. (NASDAQ:STRO) can tell us which group is most powerful. With 69% stake, institutions possess the maximum shares in the company. In other words ...
Pharmabiz6d
Sutro Biopharma & Boehringer Ingelheim BioXcellence collaboration: Established first-in-class cell-free capabilities at commercial scale
Boehringer Ingelheim BioXcellence and Sutro Biopharma Inc. announced that they successfully applied Sutro’s proprietary cell-free expression technology on a commercial scale to manufacture luveltamab ...
BioSpace8d
Sutro Biopharma to Present at the 43rd Annual J.P. Morgan Healthcare Conference
SOUTH SAN FRANCISCO, Calif., Jan. 07, 2025 (GLOBE NEWSWIRE) -- Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), a clinical-stage oncology company pioneering site-specific and novel-format ...